SEIA
GILD icon

Signature Estate & Investment Advisors’s Gilead Sciences GILD Stock Holding History

Signature Estate & Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
2,039
+163
+9% +$21.5K ﹤0.01% 585
2026
Q1 		$262K Buy
1,876
+60
+3% +$8.4K 0.01% 561
2025
Q4 		$223K Sell
1,816
-34
-2% -$4.13K ﹤0.01% 565
2025
Q3 		$205K Buy
+1,850
New +$210K ﹤0.01% 573

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Signature Estate & Investment Advisors's GILD Position: Q2 2026 in Review

Signature Estate & Investment Advisors increased its Gilead Sciences (GILD) stake by 8.7% in Q2 2026, buying an estimated $21.5K and bringing the position to 2,039 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Signature Estate & Investment Advisors first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $262K in Q1 2026. 1,448 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Signature Estate & Investment Advisors held 2,039 shares of Gilead Sciences worth $259K as of Q2 2026.
  • Signature Estate & Investment Advisors bought 163 Gilead Sciences shares in Q2 2026, an estimated $21.5K.
  • Gilead Sciences made up ﹤0.01% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #585 holding.
  • Signature Estate & Investment Advisors first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Signature Estate & Investment Advisors's Gilead Sciences position peaked at $262K in Q1 2026.
  • 1,448 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.